{"transactions":[{"id":2316976,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-29T01:06:03.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":48376,"price":0.4848,"value":23452.6848,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs."}],"balance_after":483286,"source":{"system":"sec-edgar","filing":"0001209191-22-021396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919122021396/doc4.xml","form_type":"4"}},{"id":2316975,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-29T01:06:03.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":199094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award."}],"balance_after":531662,"source":{"system":"sec-edgar","filing":"0001209191-22-021396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919122021396/doc4.xml","form_type":"4"}},{"id":2383027,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-22T22:14:03.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":430000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":430000,"derivative":{"exercise_price":0.46,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":430000},"source":{"system":"sec-edgar","filing":"0001209191-22-011791","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919122011791/doc4.xml","form_type":"4"}},{"id":2779878,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-18T20:36:47.000Z","date":"2021-03-16","kind":"purchase","acquired":true,"shares":142857,"price":1.75,"value":249999.75,"ownership":{"direct":true},"balance_after":332568,"source":{"system":"sec-edgar","filing":"0001209191-21-021771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919121021771/doc4.xml","form_type":"4"}},{"id":2864252,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-12T22:26:11.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":430000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a four year period commencing on March 11, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":430000,"derivative":{"exercise_price":3.06,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":430000},"source":{"system":"sec-edgar","filing":"0001209191-21-010267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919121010267/doc4.xml","form_type":"4"}},{"id":3214046,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-12T20:46:05.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":388800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":388800,"derivative":{"exercise_price":2.12,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":388800},"source":{"system":"sec-edgar","filing":"0001209191-20-018556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919120018556/doc4.xml","form_type":"4"}},{"id":3214045,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-12T20:46:05.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":41200,"derivative":{"exercise_price":2.12,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0001209191-20-018556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919120018556/doc4.xml","form_type":"4"}},{"id":3437877,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":10000,"price":4.62,"value":46200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.55 to $4.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":189711,"source":{"system":"sec-edgar","filing":"0001209191-19-046149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919119046149/doc4.xml","form_type":"4"}},{"id":3785384,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-23T21:10:57.000Z","date":"2018-10-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended to Tsvetelina Hoang, Mr. Hoang's wife who serves as the Company's Vice President, Research and Development. One fifth of the shares vest ten months after the grant date, the remainder of the shares vest in monthly installments thereafter upon the continued employment of Dr. Hoang by the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, October 19, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended to Tsvetelina Hoang, Mr. Hoang's wife who serves as the Company's Vice President, Research and Development. One fifth of the shares vest ten months after the grant date, the remainder of the shares vest in monthly installments thereafter upon the continued employment of Dr. Hoang by the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, October 19, 2018."}],"balance_after":200000,"derivative":{"exercise_price":9.18,"expiration_date":"2028-10-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-18-054994","document":"tv505273_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418054994/tv505273_form4.xml","form_type":"4"}},{"id":3785383,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-23T21:10:57.000Z","date":"2018-10-19","kind":"grant","acquired":true,"shares":1359855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended. These options vest and are exercisable immediately. The option exercise price is the closing price on the date of the grant, October 19, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended. These options vest and are exercisable immediately. The option exercise price is the closing price on the date of the grant, October 19, 2018."}],"balance_after":1359855,"derivative":{"exercise_price":9.18,"expiration_date":"2028-10-19","underlying":"Common Stock","underlying_shares":1359855},"source":{"system":"sec-edgar","filing":"0001144204-18-054994","document":"tv505273_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418054994/tv505273_form4.xml","form_type":"4"}},{"id":4202664,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2017-09-25T19:11:47.000Z","date":"2017-09-22","kind":"tax_withholding","acquired":false,"shares":70289,"price":3.18,"value":223519.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the restricted stock award."}],"balance_after":179711,"source":{"system":"sec-edgar","filing":"0001144204-17-049443","document":"v475755_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420417049443/v475755_4.xml","form_type":"4"}},{"id":4202663,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2017-09-25T19:11:47.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":250000,"price":3.18,"value":795000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of fully vested restricted stock issued under the Company's 2014 Omnibus Stock Ownership Plan in connection with initial employment as President and Chief Executive Officer and the execution of employment agreement."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001144204-17-049443","document":"v475755_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420417049443/v475755_4.xml","form_type":"4"}},{"id":4497831,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Bus. Development"}}],"security":"Restricted Stock Units","published_at":"2017-01-05T19:18:03.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of BLCM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2018."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001358403-17-000019","document":"wf-form4_148366186920859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840317000019/wf-form4_148366186920859.xml","form_type":"4"}},{"id":4497830,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":128751,"kind":"person","name":"Hoang Peter L.","position":1,"cik":"0001626893","reported_name":"Hoang Peter L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Bus. Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-01-05T19:18:03.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 3, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":11250,"derivative":{"exercise_price":13.89,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001358403-17-000019","document":"wf-form4_148366186920859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840317000019/wf-form4_148366186920859.xml","form_type":"4"}}]}